Boston Scientific (BSX) Stock Insights
BSX$42.43-2.63 -5.84%
$61.49B
Market Cap
18.38
P/E
13.14
Forward P/E
68
Score
Boston Scientific (BSX) Stock Insights
BSX price $42.43 -2.63 -5.84%
- Ticker
- BSX
- Price
- $42.43
- Change
- -2.63 -5.84%
- Market cap ?
- $61.49B
- P/E ?
- 18.38
- Forward P/E ?
- 13.14
- Dividend yield ?
- 0.00%
- Beta ?
- 0.57
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 68
- Value
- 74
- Quality
- 61
- Growth
- 70
Stocklytics score rationale: value 74, quality 61, growth 70.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 8386000000 | 9048000000 | 9823000000 | 10735000000 | 9913000000 | 11888000000 | 12682000000 | 14240000000 | 16747000000 | 20074000000 |
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the…
Fair value
BSX fair value $92.10. Price $42.43. Price is 54% below fair value.
Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.62B. Growth 10.02%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.45B. Net debt 10.37B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-02-03 | — | 0.83 | — | 5.42B |
| 2026-10-28 | 0.73 | 0.72 | 5.14B | 5.06B |
| 2026-07-29 | 0.86 | 0.83 | 5.44B | 5.38B |
| 2026-04-22 | 0.80 | 0.79 | 5.20B | 5.17B |
| 2026-02-04 | 0.80 | 0.78 | 5.29B | 5.28B |
| 2025-10-22 | 0.75 | 0.71 | 5.07B | 4.97B |
| 2025-07-23 | 0.75 | 0.72 | 5.06B | 4.89B |
| 2025-04-23 | 0.75 | 0.67 | 4.66B | 4.57B |
| 2025-02-05 | 0.70 | 0.66 | 4.56B | 4.42B |
| 2024-10-23 | 0.63 | 0.59 | 4.21B | 4.04B |
| 2024-07-24 | 0.62 | 0.58 | 4.12B | 4.03B |
| 2024-04-24 | 0.56 | 0.51 | 3.86B | 3.68B |
| 2024-01-31 | 0.55 | 0.51 | 3.73B | 3.59B |
| 2023-10-26 | 0.50 | 0.48 | 3.53B | 3.47B |
| 2023-07-27 | 0.53 | 0.49 | 3.60B | 3.50B |
| 2023-04-26 | 0.47 | 0.43 | 3.39B | 3.16B |
| 2023-02-01 | 0.45 | 0.47 | 3.24B | 3.24B |
| 2022-10-26 | 0.43 | 0.44 | 3.17B | 3.14B |
| 2022-07-27 | 0.44 | 0.42 | 3.24B | 3.22B |
| 2022-04-27 | 0.39 | 0.38 | 3.03B | 2.96B |
| 2022-02-02 | 0.45 | 0.44 | 3.13B | 3.11B |
| 2021-10-27 | 0.41 | 0.40 | 2.93B | 3.00B |
| 2021-07-27 | 0.40 | 0.37 | 3.08B | 3.02B |
| 2021-04-28 | 0.37 | 0.30 | 2.75B | 2.62B |
| 2021-02-03 | 0.23 | 0.31 | 2.71B | 2.81B |
| 2020-10-28 | 0.37 | 0.25 | 2.66B | 2.28B |
| 2020-07-29 | 0.08 | 0.02 | 2.00B | 500.75M |
| 2020-04-29 | 0.28 | 0.33 | 2.54B | 2.82B |
| 2020-02-05 | 0.46 | 0.44 | 2.90B | 2.78B |
| 2019-10-23 | 0.39 | 0.38 | 2.71B | 2.64B |
| 2019-07-24 | 0.39 | 0.38 | 2.63B | 2.56B |
| 2019-04-24 | 0.35 | 0.36 | 2.49B | 2.56B |
| 2019-02-06 | 0.39 | 0.37 | 2.56B | 2.43B |
| 2018-10-24 | 0.35 | 0.34 | 2.39B | 2.32B |
| 2018-07-25 | 0.41 | 0.34 | 2.49B | 2.42B |
| 2018-04-25 | 0.33 | 0.31 | 2.38B | 2.31B |
| 2018-02-01 | 0.34 | 0.34 | 2.41B | 2.41B |
| 2017-10-26 | 0.31 | 0.31 | 2.22B | 2.22B |
| 2017-07-27 | 0.32 | 0.31 | 2.26B | 2.19B |
| 2017-04-27 | 0.29 | 0.30 | 2.16B | 2.23B |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-02 | O'Connor Padraig Andrew | Buy | 1.17K | — | — |
| 2026-09-02 | O'Connor Padraig Andrew | Sell | 567 | $48.37 | 27.43K |
| 2026-09-02 | O'Connor Padraig Andrew | Sell | 1.17K | — | — |
| 2026-08-25 | Morano Susan E | Buy | 2.04K | $49.22 | 100.41K |
| 2026-08-11 | Woodworth Emily | Buy | 2.93K | $51.19 | 149.99K |
| 2026-08-10 | Monson Jonathan | Buy | 9.91K | $50.46 | 499.96K |
| 2026-08-05 | Habiger David C | Buy | 2.10K | $47.59 | 99.94K |
| 2026-08-04 | Habiger David C | Buy | 140 | $48.59 | 6.80K |
| 2026-08-03 | Habiger David C | Buy | 1.04K | $48.07 | 50.08K |
| 2026-08-03 | Mahoney Michael F | Buy | 186.24K | $48.33 | 9.00M |
| 2026-08-03 | Mahoney Michael F | Buy | 22.12K | $48.43 | 1.07M |
| 2026-07-31 | LUDWIG EDWARD J | Buy | 5.00K | $45.48 | 227.40K |
| 2026-07-31 | Fitzgerald Joseph Michael | Buy | 64.20K | $46.73 | 3.00M |
| 2026-07-01 | Monson Jonathan | Buy | 2.09K | — | — |
| 2026-07-01 | Monson Jonathan | Sell | 1.01K | $43.06 | 43.49K |
| 2026-07-01 | Monson Jonathan | Sell | 2.09K | — | — |
| 2026-05-28 | Mahoney Michael F | Sell | 386.75K | — | — |
| 2026-05-20 | Pegus Cheryl | Buy | 1.77K | $56.49 | 99.99K |
| 2026-05-20 | LUDWIG EDWARD J | Buy | 3.58K | $56.68 | 202.91K |
| 2026-05-20 | Habiger David C | Buy | 2.25K | $55.92 | 125.82K |
| 2026-05-19 | Habiger David C | Buy | 2.20K | $56.95 | 125.28K |
| 2026-05-07 | Zane Ellen M | Buy | 3.80K | — | — |
| 2026-05-07 | WICHMANN DAVID S | Buy | 3.80K | — | — |
| 2026-05-07 | Weber Christophe Pierre | Buy | 1.14K | — | — |
| 2026-05-07 | Weber Christophe Pierre | Buy | 2.66K | — | — |
| 2026-05-07 | Weber Christophe Pierre | Buy | 1.77K | — | — |
| 2026-05-07 | Smith Cathy R | Buy | 2.21K | — | — |
| 2026-05-07 | Smith Cathy R | Buy | 3.80K | — | — |
| 2026-05-07 | Pegus Cheryl | Buy | 1.28K | — | — |
| 2026-05-07 | Pegus Cheryl | Buy | 3.80K | — | — |
| 2026-05-07 | Morano Susan E | Buy | 1.28K | — | — |
| 2026-05-07 | Morano Susan E | Buy | 3.80K | — | — |
| 2026-05-07 | Mega Jessica L | Buy | 3.80K | — | — |
| 2026-05-07 | LUDWIG EDWARD J | Buy | 3.80K | — | — |
| 2026-05-07 | Habiger David C | Buy | 3.80K | — | — |
| 2026-05-02 | O'Connor Padraig Andrew | Buy | 1.80K | — | — |
| 2026-05-02 | O'Connor Padraig Andrew | Sell | 872 | $56.50 | 49.27K |
| 2026-05-02 | O'Connor Padraig Andrew | Sell | 1.80K | — | — |
| 2026-05-02 | Butcher Arthur C | Buy | 2.10K | — | — |
| 2026-05-02 | Butcher Arthur C | Sell | 1.01K | $56.50 | 56.90K |
| 2026-05-02 | Butcher Arthur C | Sell | 2.10K | — | — |
| 2026-03-02 | Pegus Cheryl | Buy | 24 | — | — |
| 2026-03-02 | Morano Susan E | Buy | 24 | — | — |
| 2026-03-02 | Weber Christophe Pierre | Buy | 323 | — | — |
| 2026-03-02 | Weber Christophe Pierre | Buy | 556 | — | — |
| 2026-03-02 | Smith Cathy R | Buy | 323 | — | — |
| 2026-03-02 | Smith Cathy R | Buy | 556 | — | — |
| 2026-03-01 | Woodworth Emily | Buy | 838 | — | — |
| 2026-03-01 | Woodworth Emily | Sell | 372 | $76.85 | 28.59K |
| 2026-03-01 | Woodworth Emily | Sell | 838 | — | — |
| 2026-02-19 | Butcher Arthur C | Buy | 6.85K | $75.76 | 519.03K |
| 2026-02-18 | Weber Christophe Pierre | Other | 0 | — | — |
| 2026-02-18 | Smith Cathy R | Other | 0 | — | — |
| 2026-02-16 | O'Connor Padraig Andrew | Buy | 905 | — | — |
| 2026-02-16 | O'Connor Padraig Andrew | Sell | 339 | $74.73 | 25.33K |
| 2026-02-16 | O'Connor Padraig Andrew | Sell | 905 | — | — |
| 2026-02-16 | Woodworth Emily | Buy | 637 | — | — |
| 2026-02-16 | Woodworth Emily | Sell | 283 | $74.73 | 21.15K |
| 2026-02-16 | Woodworth Emily | Sell | 637 | — | — |
| 2026-02-16 | Monson Jonathan | Buy | 990 | — | — |
| 2026-02-16 | Monson Jonathan | Sell | 440 | $74.73 | 32.88K |
| 2026-02-16 | Monson Jonathan | Sell | 990 | — | — |
| 2026-02-16 | O'Sullivan Miriam | Buy | 990 | — | — |
| 2026-02-16 | O'Sullivan Miriam | Sell | 291 | $74.73 | 21.75K |
| 2026-02-16 | O'Sullivan Miriam | Sell | 990 | — | — |
| 2026-02-16 | Mahoney Michael F | Buy | 16.27K | — | — |
| 2026-02-16 | Mahoney Michael F | Sell | 7.87K | $74.73 | 587.75K |
| 2026-02-16 | Mahoney Michael F | Sell | 16.27K | — | — |
| 2026-02-16 | Fitzgerald Joseph Michael | Buy | 3.96K | — | — |
| 2026-02-16 | Fitzgerald Joseph Michael | Sell | 1.81K | $74.73 | 134.96K |
| 2026-02-16 | Fitzgerald Joseph Michael | Sell | 3.96K | — | — |
| 2026-02-16 | Butcher Arthur C | Buy | 2.55K | — | — |
| 2026-02-16 | Butcher Arthur C | Sell | 1.23K | $74.73 | 91.84K |
| 2026-02-16 | Butcher Arthur C | Sell | 2.55K | — | — |
| 2026-02-16 | Brown Vance R | Buy | 1.84K | — | — |
| 2026-02-16 | Brown Vance R | Sell | 890 | $74.73 | 66.51K |
| 2026-02-16 | Brown Vance R | Sell | 1.84K | — | — |
| 2026-02-14 | O'Connor Padraig Andrew | Buy | 1.19K | — | — |
| 2026-02-14 | O'Connor Padraig Andrew | Sell | 449 | $74.73 | 33.55K |
| 2026-02-14 | O'Connor Padraig Andrew | Sell | 1.19K | — | — |
| 2026-02-14 | Woodworth Emily | Buy | 661 | — | — |
| 2026-02-14 | Woodworth Emily | Sell | 296 | $74.73 | 22.12K |
| 2026-02-14 | Woodworth Emily | Sell | 661 | — | — |
| 2026-02-14 | Monson Jonathan | Buy | 1.06K | — | — |
| 2026-02-14 | Monson Jonathan | Sell | 470 | $74.73 | 35.12K |
| 2026-02-14 | Monson Jonathan | Sell | 1.06K | — | — |
| 2026-02-14 | O'Sullivan Miriam | Buy | 1.12K | — | — |
| 2026-02-14 | O'Sullivan Miriam | Sell | 329 | $74.73 | 24.59K |
| 2026-02-14 | O'Sullivan Miriam | Sell | 1.12K | — | — |
| 2026-02-14 | Mahoney Michael F | Buy | 16.52K | — | — |
| 2026-02-14 | Mahoney Michael F | Sell | 7.99K | $74.73 | 597.09K |
| 2026-02-14 | Mahoney Michael F | Sell | 16.52K | — | — |
| 2026-02-14 | Fitzgerald Joseph Michael | Buy | 4.36K | — | — |
| 2026-02-14 | Fitzgerald Joseph Michael | Sell | 1.99K | $74.73 | 148.71K |
| 2026-02-14 | Fitzgerald Joseph Michael | Sell | 4.36K | — | — |
| 2026-02-14 | Butcher Arthur C | Buy | 3.17K | — | — |
| 2026-02-14 | Butcher Arthur C | Sell | 1.53K | $74.73 | 114.71K |
| 2026-02-14 | Butcher Arthur C | Sell | 3.17K | — | — |
| 2026-02-14 | Brown Vance R | Buy | 1.85K | — | — |
| 2026-02-14 | Brown Vance R | Sell | 895 | $74.73 | 66.88K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 1.58K, holders -191 vs prior quarter. Ownership 90.62%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 129.68M | -2.14M | -1.62% | 5.53B |
| VANGUARD CAPITAL MANAGEMENT LLC | 97.09M | 675.99K | +0.70% | 4.14B |
| STATE STREET CORP | 70.11M | 2.12M | +3.12% | 2.99B |
| PRIMECAP MANAGEMENT CO/CA/ | 50.52M | 17.99M | +55.31% | 2.16B |
| FMR LLC | 45.70M | -28.52M | -38.43% | 1.95B |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 24.86M | 13.86M | +126.06% | 1.50B |
| GEODE CAPITAL MANAGEMENT, LLC | 33.44M | 154.34K | +0.46% | 1.42B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 29.79M | -3.42K | -0.01% | 1.27B |
| D. E. SHAW & CO., INC. | 25.46M | 1.15M | +4.71% | 1.09B |
| JPMORGAN CHASE & CO | 23.91M | -9.44M | -28.31% | 1.04B |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 23.29M | 9.40M | +67.68% | 994.18M |
| NORGES BANK | 21.17M | 21.17M | New | 903.54M |
| TWO SIGMA INVESTMENTS, LP | 19.36M | 9.95M | +105.70% | 826.24M |
| MORGAN STANLEY | 18.95M | -3.32M | -14.91% | 808.66M |
| JUPITER TOPCO LLC | 18.82M | 18.82M | New | 803.36M |
| BOLLARD GROUP LLC | 18.42M | -111.45K | -0.60% | 786.20M |
| GOLDMAN SACHS GROUP INC | 16.95M | -1.94M | -10.25% | 723.61M |
| CAPITAL WORLD INVESTORS | 16.81M | 1.50M | +9.81% | 717.60M |
| UBS GROUP AG | 16.35M | 1.53M | +10.31% | 697.92M |
| JANE STREET GROUP, LLC | 16.09M | 12.05M | +298.96% | 686.58M |
| WELLINGTON MANAGEMENT GROUP LLP | 15.30M | -3.53M | -18.75% | 653.08M |
| AMUNDI | 14.30M | 173.21K | +1.23% | 610.16M |
| CAPITAL RESEARCH GLOBAL INVESTORS | 14.18M | 7.10M | +100.27% | 605.26M |
| INVESCO LTD. | 13.80M | 4.75M | +52.46% | 589.02M |
| FRANKLIN TEMPLETON INC | 13.77M | -726.42K | -5.01% | 587.80M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2010 | Cardiovascular: 3271000000.0 |
| FY2011 | Cardiac Rhythm Management: 2087000000.0, Electrophysiology: 147000000.0, Endoscopy: 1187000000.0, Interventional Cardiology: 2495000000.0, Neuromodulation: 336000000.0, Peripheral Interventions: 731000000.0, Urology / Women's Health: 498000000.0 |
| FY2012 | Cardiac Rhythm Management: 1908000000.0, Electrophysiology: 147000000.0, Endoscopy: 1252000000.0, Interventional Cardiology: 2179000000.0, Neuromodulation: 367000000.0, Peripheral Interventions: 774000000.0, Urology / Women's Health: 500000000.0 |
| FY2013 | Cardiovascular: 2867000000.0, MedSurg: 2298000000.0 |
| FY2014 | Cardiovascular: 2953000000.0, MedSurg: 2359000000.0 |
| FY2015 | Cardiovascular: 3217000000.0, MedSurg: 2669000000.0 |
| FY2016 | Cardiovascular: 3617000000.0, MedSurg: 3204000000.0 |
| FY2017 | Cardiovascular: 3500000000.0, MedSurg: 3377000000.0 |
| FY2018 | Cardiovascular: 3777000000.0, MedSurg: 3007000000.0 |
| FY2019 | Cardiovascular: 4208000000.0, MedSurg: 3307000000.0 |
| FY2020 | Cardiovascular: 3876000000.0, MedSurg: 3066000000.0 |
| FY2021 | Cardiac Rhythm Management: 3293000000.0, Cardiovascular: 4858000000.0, MedSurg: 3724000000.0 |
| FY2022 | Cardiovascular: 8161000000.0, MedSurg: 5057000000.0 |
| FY2023 | Cardiovascular: 8819000000.0, MedSurg: 5422000000.0 |
| FY2024 | Cardiovascular: 10755000000.0, MedSurg: 5993000000.0 |
| FY2025 | Cardiovascular: 13266000000.0, MedSurg: 6829000000.0 |
| Period | Value |
|---|---|
| FY2010 | Inter Continental: 727000000.0, Other Foreign Countries: 2499000000.0, United States: 4335000000.0 |
| FY2011 | Segment, Geographical, Groups of Countries, Group One: 1781000000.0, Segment, Geographical, Groups of Countries, Group Two: 726000000.0, UNITED STATES: 4010000000.0 |
| FY2012 | Segment, Geographical, Groups of Countries, Group One: 1708000000.0, Segment, Geographical, Groups of Countries, Group Two: 836000000.0, UNITED STATES: 3756000000.0 |
| FY2018 | Non-US: 4286000000.0, UNITED STATES: 5538000000.0 |
| FY2019 | Non-US: 4569000000.0, UNITED STATES: 6167000000.0 |
| FY2020 | Non-US: 4212000000.0, UNITED STATES: 5701000000.0 |
| FY2021 | Non-US: 4978000000.0, UNITED STATES: 6911000000.0 |
| FY2022 | Non-US: 5111000000.0, UNITED STATES: 7632000000.0 |
| FY2023 | Non-US: 5816000000.0, UNITED STATES: 8425000000.0 |
| FY2024 | Non-US: 6538000000.0, UNITED STATES: 10210000000.0 |
| FY2025 | Non-US: 7210000000.0, UNITED STATES: 12864000000.0 |
Insights · Dividends · Forecast · Financials · Learn